ADVI Health’s Irina Yermilov, MD, MPH, MS, Cynthia Campos, MPH, Eunice Chang, PhD, and Michael S. Broder, MD, MSHS co-authored an abstract that will be presented at this year’s 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, on December 8th from 6-8 pm PT. The abstract titled, “A Medical Chart Review of Healthcare Costs in Patients with Systemic Amyloid Light Chain Amyloidosis by Mayo 2012 Stage in the United States,” will be presented by City of Hope’s Michael Rosenzweig, MD.
A second abstract, titled “United States (US) Expert Consensus on Defining Intolerance to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Phase Chronic Myeloid Leukemia (CML),” co-authored by ADVI’s Michael S. Broder, MD, MSHS and Hannah Mattson, MPH will be presented by Moffitt Cancer Center’s Onyee Chan, MD on December 9 from 6-8 pm PT.
Get in touch to learn more about our expertise and insights.
ADVI Team
Irina Yermilov, MD, MPH, MS
Senior Director
Cynthia Campos, MPH
Senior Researcher
Eunice Chang, PhD
Chief Statistician
Michael Broder, MD
Chief Economist
Hannah Mattson, MPH
Senior Project Manager
